COVID-19 Archives - BioPharmaJournal

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study...

Kate Hudson - November 9, 2021 0

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives FDA Minutes On Pre-IND...

Gavins Felicity - September 2, 2021 0

Humanigen Inc (NASDAQ:HGEN) Demonstrates Improved Survival Of COVID-19 Patients In Phase...

Kate Hudson - May 4, 2021 0

Humanigen Inc. (NASDAQ:HGEN) Announce Encouraging Phase 3 Lenzilumab Study Results...

Kate Hudson - April 1, 2021 0

Vaxart Inc. (NASDAQ:VXRT) to Commence Phase Two Study Of Its Oral...

Kate Hudson - March 3, 2021 0

Amarin Corporation plc (NASDAQ:AMRN) Presents VASCEPA® Clinical Study Findings At The...

Matt Wade - February 3, 2021 0

Novavax Inc. (NASDAQ:NVAX) Enters COVID-19 Vaccine Supply Deals With the EU...

Ward Sport - January 27, 2021 0

Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The...

Kate Hudson - January 19, 2021 0

AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Reports Study Progress of Ampligen Combination As...

Ward Sport - December 17, 2020 0

Vaxart Inc. (NASDAQ:VXRT) Reports Q3 Financial Results And Progress of COVID-19...

Kate Hudson - December 7, 2020 0

12 3...11 Page 1 of 11

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Announce Update Regarding Vupanorsen Study In...

Matt Wade - December 8, 2021 0

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) has announced that Pfizer Inc. (NYSE: PFE) has given an update on the Phase 2b vupanorsen study. Vupanorsen is...

Artelo Biosciences Inc. (NASDAQ: ARTL) Announce Fiscal Year 2021 Results And...

December 8, 2021

Seelos Therapeutics Inc. (NASDAQ: SEEL) Announce License Agreement With iX Biopharma...

December 8, 2021

BioCryst Pharmaceutical Inc. (NASDAQ: BCRX) Commences Enrolment in REDEEM-2 Study Evaluating...

December 7, 2021

Ocuphire Pharma Inc. (NASDAQ: OCUP) Enrols First Subjects in Phase 3...

December 7, 2021

Tag: COVID-19

Recent Post